Our team combines patient - centered comprehensive care with state - of - the - art technology and research to provide the best possible outcomes for
pediatric brain tumor patients.
Not exact matches
In this conference, members of the U-M
pediatric brain tumor team and physicians from leading national
brain tumor institutions incorporate molecular results from
pediatric brain tumors (Mi - Oncoseq and molecular pathology) into targeted treatments for
patients.
The St. Jude Children's Research Hospital - Washington University
Pediatric Cancer Genome Project has identified new mutations in
pediatric brain tumors known as high - grade gliomas (HGGs), which most often occur in the youngest
patients.
Our groundbreaking
Pediatric Mi - Oncoseq Program is an internationally known precision oncology program focusing on the genetic analysis of
pediatric cancer
patients including in children with malignant
brain tumors, and determines whether targeted treatments may be available based upon their personalized
tumor genomic sequencing profiles.